Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Marina Cavazzana, MD
Researcher Head
Department of Biotherapy
Hôpital Necker
149 Rue de Sèvres
Paris, France
Marina Cavazzana is a pediatrician, Professor of Haematology since 2000, Head of the Biotherapy Department at Hospital Necker, University Paris Descartes. She is the Director of the Inserm / Assistance Publique – Hôpitaux de Paris GHU Ouest Biotherapy Clinical Investigation Center and leads a research Laboratory at Imagine Institute. She studied medicine in Padua, Italy and received Doctorate of Medicine in 1983, her certification in Paediatrics in 1987 and a PhD in Life Sciences in 1993 (University Paris VII).
Dr. Marina Cavazzana has dedicated her time and research in investigating innovative protocol with a particular intervention gene therapy, focusing on sickle cell disease.
Her main research and clinical interests are development of the immune system, genetic diseases of the haematopoietic system and cell and gene therapy. Her group studies the means to improve the clinical results of hematopoietic stem cell transplantation, crossing HLA-barriers, and the differentiation of mouse and human stem cells towards lymphocyte lineages. She has initiated several clinical trials based on the use of ex vivo gene modified cells to treat patients with inherited disorders, the preliminary clinical results of which are encouraging.
She is the author or co-author of one patent and of more than 270 publications in peer-reviewed journals.
Representative Publications:
Gene Therapy in a Patient with Sickle Cell Disease
+myBinderRelated Content
-
Ugochi O. Ogu, MDDr. Ogu currently serves as an Assistant...
-
Sickle Cell Disease in the Emergency Department: Confronting Barriers to Care“You’re too pretty to have a disease...
-
Lewis Hsu, MD, PhDDr. Lewis Hsu is a pediatric hematologis...
-
Virginia Commonwealth University, Massey Cancer CenterVCU Massey Cancer Center is among the to...
-
My medical school lesson was tinged with racism. Did that affect how I treated a sickle cell patient years later?The young woman was curled up in a ball....
-
The Affordable Care Act Improves Healthcare Access and Utilization Among Young Adults with Sickle Cell DiseaseIntroduction: The Dependent Coverage Pro...
-
Unanticipated consequences identified after implementation of a pediatric emergency department (PED)-based intranasa...Background: The 2014 National Heart Lun...
